Meanings of adoptive immunotherapy in English

Aiming to relieve the radiation and antitumor drugs, adoptive immunotherapy is greatly expectant.

This approach may have important therapeutic implications for adoptive immunotherapy.

Here, we describe the development of a novel adoptive immunotherapy specific for this disease.

Here, we review these mechanisms and focus on the effect of Toll-like receptor agonists in adoptive immunotherapy.

We have thus sought ways to enhance the effectiveness of adoptive immunotherapy while minimizing its toxic side effects.

We describe here a complete clinical-grade generation of human anti-ADV cytotoxic T cells to propose an adoptive immunotherapy.

This study suggests that CIK cells may be used as an adoptive immunotherapy for patients with ovarian cancer.

The chimeric state after allogeneic hematopoietic stem cell transplantation provides a platform for adoptive immunotherapy using donor-derived immune cells.

Current protocols used to select CMV-specific T cells for adoptive immunotherapy focus on virus-specific memory T cells from seropositive donors.

Cellular adoptive immunotherapy for virus-associated malignant disease is an attractive strategy, since viral antigens provide targets for specific T lymphocytes.

These results support future clinical investigation of the use of purified NK cells for adoptive immunotherapy in the absence of ATG.

Sentinel node lymphocytes represents an enriched source of tumour reactive lymphocytes, and may be useful in future trials of adoptive immunotherapy.

A promising solution is the application of adoptive immunotherapy approaches such as ex vivo generated EBV-specific CTLs for prevention and therapy.

Our data suggest that adoptive immunotherapy approaches to the treatment of cancer patients may be enhanced using Bcl-2-modified tumor-reactive T cells.

The protocol combines the biosafety of peptide-based approaches with HLA type independence and may help to advance adoptive immunotherapy in the future.

In this study, we used trichimeras to evaluate strategies for adoptive immunotherapy to solid tumors, using the kidney as a tumor surrogate.